Stock A389030 GENINUS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company GENINUS Inc.

Equities

A389030

KR7389030008

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
1,930 KRW +1.21% Intraday chart for GENINUS Inc. +5.12% -26.62%
2021 GENINUS Inc. has completed an IPO in the amount of KRW 40 billion. CI
2021 GENINUS Inc. has filed an IPO. CI

Business Summary

Geninus Inc is a Korea-based company principally engaged in the bioinformatics analysis business. The Company is engaged in the provision of single cell analysis services, genetic testing for disease prediction for the public, cancer genome analysis solutions based on tissue biopsy and other services. It is also engaged personal genetic testing, software development, rental business and others.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Next Generation Sequencing
66.7 %
8,961 88.9 % 4,650 66.7 % -48.11%
Others
21.6 %
319 3.2 % 1,503 21.6 % +370.74%
Array
9.7 %
803 8.0 % 673 9.7 % -16.09%
ISH
2.0 %
- - 141 2.0 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
95.4 %
9,819 97.4 % 6,643 95.4 % -32.34%
America
4.2 %
243 2.4 % 291 4.2 % +19.75%
Asia
0.5 %
22 0.2 % 33 0.5 % +50.38%

Managers

Managers TitleAgeSince
Woong-Yang Park CEO
 Chief Executive Officer 61 31/03/18
William Ku DFI
 Director of Finance/CFO 38 30/11/20
Dong-Hyun Park CTO
 Chief Tech/Sci/R&D Officer 52 31/05/19
Yong-Ju Bang COO
 Chief Operating Officer 68 31/03/18
Jung-Ho Song AUD
 Comptroller/Controller/Auditor 40 -

Members of the board

Members of the board TitleAgeSince
Gang-Soo Lee BRD
 Director/Board Member 54 -
William Ku DFI
 Director of Finance/CFO 38 30/11/20
Woong-Yang Park CEO
 Chief Executive Officer 61 31/03/18
Yong-Ju Bang COO
 Chief Operating Officer 68 31/03/18
Jung-Kyu Han BRD
 Director/Board Member 61 -
Chan-Woo Kook BRD
 Director/Board Member 43 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 33,331,845 20,507,665 ( 61.53 %) 0 61.53 %

Shareholders

NameEquities%Valuation
Woong-Yang Park
30.60 %
10,200,000 30.60 % 13 M ₩
KB Investment Co., Ltd.
11.81 %
3,935,038 11.81 % 5 M ₩
Yong-Ju Bang
5.768 %
1,922,528 5.768 % 2 M ₩
Company K Partners Ltd. (Private Equity)
3.036 %
1,012,069 3.036 % 1 M ₩
GENINUS, Inc. ESOA
0.9000 %
300,000 0.9000 % 375 951 ₩
William Ku
0.3000 %
100,000 0.3000 % 125 317 ₩
Sang-hyuk Lee
0.0150 %
5,000 0.0150 % 6 266 ₩

Company contact information

GENINUS, Inc.

4-5 Floor, KDU Tower 70 Jeongui-ro

05836, Seoul

+

http://www.kr-geninus.com
address GENINUS Inc.(A389030)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sales per region

Sector Bio Diagnostics & Testing

1st Jan change Capi.
GENINUS INC. Stock GENINUS Inc.
-26.62% 47.54M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-31.90% 9.3B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-6.25% 3.1B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+25.95% 2.87B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-13.96% 2.17B
VERACYTE, INC. Stock Veracyte, Inc.
-16.83% 1.75B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+72.82% 1.5B
CAREDX, INC Stock CareDx, Inc
+29.17% 807M
SEEGENE, INC. Stock Seegene, Inc.
-2.62% 759M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-26.33% 532M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. A389030 Stock
  4. Company GENINUS Inc.